HPV DNA as a biomarker in oropharyngeal cancer: A step in the right direction. Clinical cancer research : an official journal of the American Association for Cancer Research Colevas, A. D. 2022

Abstract

Lack of prospectively planned followup and minimal characterization of the patient population studied complicate interpretation of circulating HPV DNA as a prognostic biomarker for HPV associated oropharyngeal carcinoma patients treated with curative intent.

View details for DOI 10.1158/1078-0432.CCR-22-1711

View details for PubMedID 35861851